Strakan gets better-than-expected boost from blue chip VCs

The UK pharmaceutical company has received a solid £30.5m from Warburg Pincus, 3i and LMS Group.

29 December 2012•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles